Keya Medical
About Keya Medical
Keya Medical is an international medical technology company at the forefront of developing deep learning-based medical devices for disease diagnosis and treatment. The company specializes in AI-driven solutions, particularly for cardiovascular diagnosis, aiming to empower clinicians with advanced technologies that address real-world challenges. Its flagship product, DEEPVESSEL FFR, is an FDA-cleared, CE-marked, NMPA-approved, and HSA (Singapore) certified CT-FFR analysis tool. This software provides a non-invasive physiological functional assessment of coronary arteries using coronary computed tomography angiography (CCTA), generating a 3D interactive model and a comprehensive PDF report to aid in decision-making for patient care.
Keya Medical’s solutions are designed to improve the triage of patients with chest pain and suspected coronary artery disease (CAD) by offering accurate, efficient, and cost-effective diagnostic assessments. The company collaborates with medical centers and key opinion leaders globally, applying advancements in machine learning, medical informatics, and regulatory science. Beyond cardiology, Keya Medical is also developing deep learning-based medical devices across various specialties, including neurology, pulmonology, pathology, and surgery.
Focus Areas
Business Intelligence
| Key Investors | GGV Capital, Kunlun Internet Intelligent Industrial Investment Fund, Shanghai Guofang FOF, Shanghai International Group (SIG), Alwin Capital, IDG Capital, GL Ventures, GIC, Qiming Venture Partners, Boyu Capital, Beijing Kunlun Tech, Source Code Capital, Tasly Group, CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, IN CAPITAL |
| Partnerships | Precision Image Analysis (PIA), Corazon Imaging, Qinnovativ Medtech, Kanbai Tech, Bayer, CARPL.ai, Zwanger-Pesiri Radiology |
| Technology | Deep learning algorithms, deep learning neural networks, computer vision, medical image analysis, cloud-based (Ambra Intelerad's AWS platforms) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, Keya Medical's solutions, particularly DEEPVESSEL FFR, offer a precise, non-invasive, and efficient method for evaluating coronary artery disease. This can significantly enhance diagnostic accuracy, guide revascularization decisions, and reduce the need for unnecessary invasive procedures. The comprehensive anatomical and functional information provided at every point of the coronary tree allows for a more complete understanding of patient conditions. The streamlined workflow, without the need for scanner certification or extensive staff training, integrates easily into existing practices. Furthermore, the new Category I CPT code (75580) for non-invasive FFR estimates from CCTA software analysis supports reimbursement, making these advanced diagnostics more accessible and financially viable.
Keya Medical's solutions are designed for integration into clinical workflows. Their CardiSight workflow is an AI suite that integrates CCTA interpretation with DeepVessel FFR and DeepVessel Plaque analysis for a comprehensive understanding of coronary pathology. They also collaborate with partners like Precision Image Analysis (PIA) for cloud-based, on-demand post-processing services and Corazon Imaging for mobile radiology services, enabling flexible and accessible deployment of their AI FFR CT solutions.
What the Web Says
Keya Medical is an international medical technology company specializing in deep learning-based medical devices for disease diagnosis and treatment, particularly in cardiology. Their flagship products, DeepVessel FFR and DeepVessel Plaque, are AI-powered software solutions for analyzing coronary CT angiography (CCTA) images to assess coronary artery disease. Reviews for their products are generally positive, highlighting their accuracy and user-friendliness. However, employer reviews indicate a mixed sentiment, with some employees feeling overworked and underpaid.
Overall: MixedStrengths
- Reliable and user-friendly AI CT-FFR solution (DeepVessel FFR).
- Provides enhanced understanding of stenosis and flow issues through 3D models.
- Exceptional accuracy and reliability of results, aiding in informed clinical decisions.
- Advanced AI capabilities offer deeper understanding of vessel anatomy.
- DeepVessel FFR has demonstrated higher accuracy than other non-invasive tests.
- DeepVessel Plaque offers comprehensive quantitative measurements for coronary plaque analysis.
Limitations
- Some employees report being overworked, underpaid, and under-appreciated.
- Potential for the company not to be a long-term home for employees.
- One review for a related company, Keya, Inc., mentioned no advancement opportunities.
Based on reviews from: KeyaMedical (Testimonials), Indeed.com, AuntMinnie, Diagnostic Imaging, Capterra
Last updated: 2026-07-19
Videos
News, demos, and interviews about Keya Medical.
Videos load interactively. If none appear, search YouTube for Keya Medical →
Press & Coverage
Frequently Asked Questions
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]
Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]
Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]